Larkspur Health Acquisition Corp. (NASDAQ: LSPRU) disclosed that it has ended the initial public offering of 7,500,000 units at an offering price of $10.00 per unit, with each unit comprised of one share of common stock and three-fourths of one redeemable warrant. Each whole warrant will qualify thereof to buy one share of common stock at $11.50 per share.
The units are listed on The Nasdaq Global Market (Nasdaq) and commenced trading under the ticker symbol “LSPRU” on December 21, 2021. Once the securities that make up the units start separate trading, the shares of common stock and the warrants are likely to be traded on Nasdaq under the symbols “LSPR” and “LSPRW,” respectively.
Furthermore, Larkspur Health Acquisition Corp. is a blank check company sponsored by Larkspur Health LLC, a Delaware limited liability company, to accomplish a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more enterprises.
In addition, the Company strives to focus on biotechnology firms and would gain from access to public markets as well as its management teams and board of directors’ operational and strategic skills. Daniel J. O’Connor, Chairman and Chief Executive Officer, and David S. Briones, Director and Chief Financial Officer, head the company.